Ex parte LEFKOWITZ et al. - Page 2




                 Appeal No.: 1996-1307                                                                          Paper No. 34                            
                 Application No.: 08/038,072                                                                               Page 2                       
                          The examiner rejected claims 2-4, 7, and 15-19 under 35                                                                       
                 U.S.C. § 103 as being unpatentable over                                                                                                
                          R.J. Lefkowitz & M.G. Caron, "Adrenergic receptors:                                                                           
                          models for the study of receptors coupled to guanine                                                                          
                          nucleotide regulatory proteins", 263 J. Biol. Chem. 4993-                                                                     
                          96 (1988) ("Lefkowitz")                                                                                                       
                 or                                                                                                                                     
                          R.L. Huganir & P. Greengard, "Regulation of receptor                                                                          
                          function by protein phosphorylation", 8 Trends Pharm.                                                                         
                          Sci. 472-77 (1987) ("Huganir")                                                                                                
                 in view of Appellants' own admissions  (Paper No. 33 (Ex.                                                                              
                 Ans.) at 3).                                                                                                                           
                          Lefkowitz and Huganir teach that phosphorylation of the                                                                       
                 $ adrenergic receptor ("$ AR")  desensitizes the receptor to an2       1                                                                                 
                 agonist.  The desensitization may be heterologous (i.e.,                                                                               
                 without the receptor being occupied by agonist) or homologous                                                                          
                 (i.e., only occurs in agonist occupied receptor).                                                                                      
                 Heterologous desensitization is thought to be caused by                                                                                
                 phosphorylation of the $ AR by cAMP -dependent protein kinase2                  2                                                                        
                 while homologous desensitization is thought to be caused by                                                                            



                          1In referring to the $ adrenergic receptor, Appellants use                                                                    
                 the term "$ AR".  In referring to the receptor's kinase,                                                                               
                                     2                                                                                                                  
                 Appellant uses the shorthand term "$ar kinase"  (Paper No.                                                                             
                 1(Spec.) at e.g., 10, 13).  We will use the same shorthand                                                                             
                 terminology that Appellants use.                                                                                                       
                          2Cyclic adenosine monophosphate.                                                                                              





Page:  Previous  1  2  3  4  5  6  Next 

Last modified: November 3, 2007